| Baveno VII–renewing consensus in portal hypertension R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ... Journal of hepatology 76 (4), 959-974, 2022 | 1337 | 2022 |
| Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials C Camma, F Schepis, A Orlando, M Albanese, L Shahied, F Trevisani, ... Radiology 224 (1), 47-54, 2002 | 1065 | 2002 |
| Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis E Villa, C Cammà, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ... Gastroenterology 143 (5), 1253-1260. e4, 2012 | 804 | 2012 |
| Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis F Fiorica, D Di Bona, F Schepis, A Licata, L Shahied, A Venturi, AM Falchi, ... Gut 53 (7), 925-930, 2004 | 748 | 2004 |
| Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? F Schepis, C Cammà, D Niceforo, A Magnano, S Pallio, M Cinquegrani, ... Hepatology 33 (2), 333-338, 2001 | 549 | 2001 |
| Q‐T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors M Bernardi, S Calandra, A Colantoni, F Trevisani, ML Raimondo, G Sica, ... Hepatology 27 (1), 28-34, 1998 | 501 | 1998 |
| Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years M Manno, C Cammà, F Schepis, F Bassi, R Gelmini, F Giannini, F Miselli, ... Gastroenterology 127 (3), 756-763, 2004 | 356 | 2004 |
| MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 A Bellacosa, L Cicchillitti, F Schepis, A Riccio, AT Yeung, Y Matsumoto, ... Proceedings of the National Academy of Sciences 96 (7), 3969-3974, 1999 | 339 | 1999 |
| Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: a meta‐analysis of individual patient data C Camma, D Di Bona, F Schepis, EJ Heathcote, S Zeuzem, PJ Pockros, ... Hepatology 39 (2), 333-342, 2004 | 324 | 2004 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 231 | 2016 |
| The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity S Cortellino, D Turner, V Masciullo, F Schepis, D Albino, R Daniel, ... Proceedings of the National Academy of Sciences 100 (25), 15071-15076, 2003 | 165 | 2003 |
| When and how to treat acute hepatitis C? A Licata, D Di Bona, F Schepis, L Shahied, A Craxı̀, C Cammà Journal of hepatology 39 (6), 1056-1062, 2003 | 141 | 2003 |
| Consensus conference on TIPS management: techniques, indications, contraindications S Fagiuoli, R Bruno, WD Venon, F Schepis, F Vizzutti, P Toniutto, ... Digestive and Liver Disease 49 (2), 121-137, 2017 | 136 | 2017 |
| Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors D Di Vizio, L Cito, A Boccia, P Chieffi, L Insabato, G Pettinato, ML Motti, ... Oncogene 24 (11), 1882-1894, 2005 | 134 | 2005 |
| Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis L Turco, G Garcia-Tsao, I Magnani, M Bianchini, M Costetti, C Caporali, ... Journal of hepatology 68 (5), 949-958, 2018 | 126 | 2018 |
| Liver Angiopoietin‐2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals F Faillaci, L Marzi, R Critelli, F Milosa, F Schepis, E Turola, S Andreani, ... Hepatology 68 (3), 1010-1024, 2018 | 122 | 2018 |
| Validating, deconstructing and refining Baveno criteria for ruling out high‐risk varices in patients with compensated cirrhosis P Jangouk, L Turco, A De Oliveira, F Schepis, E Villa, G Garcia‐Tsao Liver International 37 (8), 1177-1183, 2017 | 118 | 2017 |
| Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis F Schepis, F Vizzutti, G Garcia-Tsao, G Marzocchi, L Rega, N De Maria, ... Clinical Gastroenterology and Hepatology 16 (7), 1153-1162. e7, 2018 | 110 | 2018 |
| Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling G Cuda, R Paternò, R Ceravolo, M Candigliota, N Perrotti, F Perticone, ... Circulation 105 (8), 968-974, 2002 | 109 | 2002 |
| Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease A Sartini, S Gitto, M Bianchini, MC Verga, M Di Girolamo, A Bertani, ... Cell death & disease 9 (2), 87, 2018 | 88 | 2018 |
